BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806X952. A total of 6 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,604,202 | +60.4% | 174,600 | +4.6% | 0.02% | +66.7% |
| Q2 2023 | $2,870,680 | -46.6% | 166,900 | -48.5% | 0.01% | -52.6% |
| Q1 2023 | $5,371,920 | +12717.8% | 324,000 | +5790.9% | 0.02% | – |
| Q4 2022 | $41,910 | -93.4% | 5,500 | -91.4% | 0.00% | -100.0% |
| Q3 2022 | $636,000 | +210.2% | 64,000 | +183.2% | 0.00% | – |
| Q2 2022 | $205,000 | -23.8% | 22,600 | -14.7% | 0.00% | – |
| Q1 2022 | $269,000 | -92.1% | 26,500 | -87.0% | 0.00% | -100.0% |
| Q4 2021 | $3,411,000 | +222.1% | 204,500 | +804.9% | 0.00% | +200.0% |
| Q3 2021 | $1,059,000 | -36.8% | 22,600 | -17.8% | 0.00% | -50.0% |
| Q2 2021 | $1,676,000 | -18.3% | 27,500 | -17.4% | 0.00% | -33.3% |
| Q1 2021 | $2,051,000 | +476.1% | 33,300 | +566.0% | 0.00% | +200.0% |
| Q4 2020 | $356,000 | +2125.0% | 5,000 | +900.0% | 0.00% | – |
| Q2 2020 | $16,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 174,600 | $4,604,202 | 0.02% |
| SIMPLEX TRADING, LLC | 282,300 | $7,444 | 0.01% |
| JANE STREET GROUP, LLC | 118,300 | $3,119,571 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |